Coordinatore | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
Nazionalità Coordinatore | France [FR] |
Totale costo | 4˙793˙026 € |
EC contributo | 3˙600˙000 € |
Programma | FP7-INFRASTRUCTURES
Specific Programme "Capacities": Research infrastructures |
Code Call | FP7-INFRASTRUCTURES-2010-1 |
Funding Scheme | CP-CSA-Infra-PP |
Anno di inizio | 2010 |
Periodo (anno-mese-giorno) | 2010-11-01 - 2014-08-31 |
# | ||||
---|---|---|---|---|
1 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
FR (PARIS) | coordinator | 749˙993.00 |
2 |
Department of Health
Organization address
address: Quarry House, Quarry Hill contact info |
UK (Leeds) | participant | 432˙369.12 |
3 |
INSERM - TRANSFERT SA
Organization address
address: Rue Watt 7 contact info |
FR (PARIS) | participant | 310˙000.00 |
4 |
OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT GMBH
Organization address
address: SPARGELFELDSTRASSE 191 contact info |
AT (WIEN) | participant | 300˙089.00 |
5 |
ISTITUTO NAZIONALE MALATTIE INFETTIVE L.SPALLANZANI - IRCCS
Organization address
address: "Via Portuense, 292" contact info |
IT (ROMA) | participant | 249˙299.00 |
6 |
ROBERT KOCH-INSTITUT
Organization address
address: Nordufer 20 contact info |
DE (Berlin) | participant | 222˙343.00 |
7 |
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE
Organization address
address: Nationalestraat 155 contact info |
BE (ANTWERPEN) | participant | 219˙276.00 |
8 |
Medizinische Universitaet Graz
Organization address
address: AUENBRUGGERPLATZ 2 contact info |
AT (GRAZ) | participant | 167˙707.00 |
9 |
BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN
Organization address
address: BERNHARD NOCHT STRASSE 74 contact info |
DE (HAMBURG) | participant | 135˙726.00 |
10 |
HEALTH PROTECTION AGENCY HPA
Organization address
address: Central Office - 7th Floor, Holborn Gate - High Holborn 330 contact info |
UK (LONDON) | participant | 134˙673.89 |
11 |
FOLKHALSOMYNDIGHETEN
Organization address
address: NOBELS VAG 18 contact info |
SE (SOLNA) | participant | 127˙726.00 |
12 |
SPITALUL CLINIC DR VICTOR BABES BUCURESTI - SVB
Organization address
address: SOSEAUA MIHAI BRAVU 281 - Sector 3 contact info |
RO (BUCURESTI) | participant | 100˙227.00 |
13 |
FRIEDRICH LOEFFLER INSTITUT - BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT
Organization address
city: GREIFSWALD-INSEL RIEMS contact info |
DE (GREIFSWALD-INSEL RIEMS) | participant | 93˙526.00 |
14 |
PHILIPPS UNIVERSITAET MARBURG
Organization address
address: Biegenstrasse 10 contact info |
DE (MARBURG) | participant | 91˙732.00 |
15 |
HACETTEPE UNIVERSITESI
Organization address
address: HACETTEPE UNIVERSITESI BEYTEPE KAMPUSU REKTORLUK BINASI contact info |
TR (CANKAYA ANKARA) | participant | 75˙201.00 |
16 |
HELLENIC PASTEUR INSTITUTE
Organization address
address: Vassilissis Sofias Avenue 127 contact info |
EL (ATHENS) | participant | 61˙026.00 |
17 |
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
Organization address
address: AVENIDA PADRE CRUZ . contact info |
PT (LISBOA) | participant | 34˙701.00 |
18 |
SLOVENSKA ZDRAVOTNICKA UNIVERZITA V BRATISLAVE
Organization address
address: LIMBOVA 12 contact info |
SK (BRATISLAVA) | participant | 34˙026.00 |
19 |
THE PIRBRIGHT INSTITUTE
Organization address
address: ASH ROAD PIRBRIGHT contact info |
UK (WOKING) | participant | 25˙552.00 |
20 |
INSTITUTO DE SALUD CARLOS III
Organization address
address: CALLE SINESIO DELGADO 4-6 contact info |
ES (MADRID) | participant | 18˙190.00 |
21 |
Nome Ente NON disponibile
Organization address
address: ALBERT FLORIAN UTCA 2-6 contact info |
HU (Budapest) | participant | 16˙617.00 |
22 |
FUNDATIA DR. VICTOR BABES
Organization address
address: SOSEAUA MIHAI BRAVU 281 SECTOR 3 contact info |
RO (BUCURESTI) | participant | 0.00 |
23 |
MARMARA UNIVERSITY
Organization address
address: GOZTEPE KAMPUSU KUYUBASI contact info |
TR (ISTANBUL) | participant | 0.00 |
24 |
SMITTSKYDDSINSTITUTET
Organization address
address: Nobels vaeg 18 contact info |
SE (SOLNA) | participant | 0.00 |
25 |
STATENS SERUM INSTITUT
Organization address
address: ARTILLERIVEJ 5 contact info |
DK (KOBENHAVN S) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'In the context of the emerging and re-emerging infectious diseases involving highly pathogenic microorganisms, European countries have to be well-prepared to face such threats. However, the Biosafety Level 4 (BSL4) capacity in Europe is not sufficient enough to cover the efficient development of diagnosis, prophylactic and therapeutics means against these pathogens. Moreover, there is no global coordination of activities and harmonization of practice in this field. Therefore, the ERINHA project proposes the creation of a top world-class BSL4 research infrastructure that will address the actual European capacity sparseness. The project plans to conduct five main actions which are: (i) Building additional BSL4 areas in several existing BSL4 laboratories, (ii) Building BSL4 laboratories in strategically selected EU countries that are lacking one, (iii) Building a support infrastructure around BSL4 laboratories mainly dedicated to host scientific visitors and staff, (iv) Setting-up the user access to the ERINHA infrastructure, (v) Establishing coordination capacities for efficient dispatching and control of all activities. For 46 months, the ERINHA Preparatory Phase will focus on (i) Identifying relevant sites in Europe for new BSL4 constructions or major upgrades, (ii) Getting political and financial commitments from National, European or International concerned entities to support construction, (iii) Establishing a secured and validated financial plan for construction, (iv) Defining and implementing an appropriate governance and legal framework, (v) Harmonising and disseminating common procedures related to L4 biological resources, biosafety and biosecurity management, (iv) Defining and implementing joint training programs to operate in BSL4 facilities, (vii) Identifying the ERINHA’s users and establishing rules for access. These achievements will allow the ERINHA project to reach the legal, financial and technical maturity to proceed to the construction phase.'
An EU-funded project is ensuring that the region has the capacity to deal with highly infectious micro-organisms in research laboratories. It will also coordinate international research activities to make sure that funding is spent efficiently in the search for diagnostics and therapies.